Birdwatch Note
2023-09-02 23:22:42 UTC - NOT_MISLEADING
The 3 events described in this tweet are an accurate synopsis of the FDA's original tweet, as well as statements made by the FDA and the judge during court proceedings. https://twitter.com/US_FDA/status/1429050070243192839?s=20 https://www.biospace.com/article/fda-sued-by-doctors-over-their-use-of-ivermectin-for-covid-19/ https://thehill.com/regulation/court-battles/4184259-federal-appeals-court-revives-lawsuit-against-fda-over-covid-19-ivermectin-messaging/
Written by A59ABE6C579A241DE8752FACC9924BAB80915785BA8E53BE2157895C0CF88367
Participant Details
Original Tweet
Tweet embedding is no longer reliably available, due to the platform's instability (in terms of both technology and policy). If the Tweet still exists, you can view it here: https://twitter.com/foo_bar/status/1697986109140304279
Please note, though, that you may need to have your own Twitter account to access that page. I am currently exploring options for archiving Tweet data in a post-API context.
All Information
- ID - 1698114257122975766
- noteId - 1698114257122975766
- participantId -
- noteAuthorParticipantId - A59ABE6C579A241DE8752FACC9924BAB80915785BA8E53BE2157895C0CF88367 Participant Details
- createdAtMillis - 1693696962996
- tweetId - 1697986109140304279
- classification - NOT_MISLEADING
- believable -
- harmful -
- validationDifficulty -
- misleadingOther - 0
- misleadingFactualError - 0
- misleadingManipulatedMedia - 0
- misleadingOutdatedInformation - 0
- misleadingMissingImportantContext - 0
- misleadingUnverifiedClaimAsFact - 0
- misleadingSatire - 0
- notMisleadingOther - 0
- notMisleadingFactuallyCorrect - 1
- notMisleadingOutdatedButNotWhenWritten - 0
- notMisleadingClearlySatire - 0
- notMisleadingPersonalOpinion - 0
- trustworthySources - 1
- summary
- The 3 events described in this tweet are an accurate synopsis of the FDA's original tweet, as well as statements made by the FDA and the judge during court proceedings. https://twitter.com/US_FDA/status/1429050070243192839?s=20 https://www.biospace.com/article/fda-sued-by-doctors-over-their-use-of-ivermectin-for-covid-19/ https://thehill.com/regulation/court-battles/4184259-federal-appeals-court-revives-lawsuit-against-fda-over-covid-19-ivermectin-messaging/
Note Status History
createdAt | timestampMillisOfFirstNonNMRStatus | firstNonNMRStatus | timestampMillisOfCurrentStatus | currentStatus | timestampMillisOfLatestNonNMRStatus | mostRecentNonNMRStatus | participantId |
2023-09-02 23:22:42 UTC (1693696962996) |
1969-12-31 23:59:59 UTC (-1) |
2023-09-04 02:38:47 UTC (1693795127504) |
NEEDS_MORE_RATINGS | 1969-12-31 23:59:59 UTC (-1) |
Note Ratings
rated at | rated by | |
2023-09-02 19:31:01 -0500 | Rating Details | |
2023-09-02 19:30:30 -0500 | Rating Details | |
2023-09-02 19:29:23 -0500 | Rating Details | |
2023-09-02 19:22:53 -0500 | Rating Details | |
2023-09-02 19:06:44 -0500 | Rating Details | |
2023-09-02 19:03:39 -0500 | Rating Details | |
2023-09-02 18:34:35 -0500 | Rating Details | |
2023-09-02 18:24:22 -0500 | Rating Details | |
2023-09-03 15:07:10 -0500 | Rating Details | |
2023-09-03 10:44:38 -0500 | Rating Details | |
2023-09-03 10:18:49 -0500 | Rating Details | |
2023-09-03 09:53:02 -0500 | Rating Details | |
2023-09-03 09:47:52 -0500 | Rating Details | |
2023-09-03 09:44:56 -0500 | Rating Details | |
2023-09-03 09:44:08 -0500 | Rating Details | |
2023-09-03 09:18:56 -0500 | Rating Details | |
2023-09-03 08:57:17 -0500 | Rating Details | |
2023-09-03 08:22:41 -0500 | Rating Details | |
2023-09-03 08:16:49 -0500 | Rating Details | |
2023-09-03 07:36:54 -0500 | Rating Details | |
2023-09-03 07:05:13 -0500 | Rating Details | |
2023-09-03 06:57:47 -0500 | Rating Details | |
2023-09-03 06:54:47 -0500 | Rating Details | |
2023-09-03 06:47:08 -0500 | Rating Details | |
2023-09-03 06:40:42 -0500 | Rating Details | |
2023-09-03 06:39:50 -0500 | Rating Details | |
2023-09-03 06:21:02 -0500 | Rating Details | |
2023-09-03 06:18:00 -0500 | Rating Details | |
2023-09-03 06:16:54 -0500 | Rating Details | |
2023-09-03 05:55:29 -0500 | Rating Details | |
2023-09-03 05:49:49 -0500 | Rating Details | |
2023-09-03 05:13:51 -0500 | Rating Details | |
2023-09-03 05:01:16 -0500 | Rating Details | |
2023-09-03 05:01:13 -0500 | Rating Details | |
2023-09-03 04:58:33 -0500 | Rating Details | |
2023-09-03 04:47:43 -0500 | Rating Details | |
2023-09-03 04:29:35 -0500 | Rating Details | |
2023-09-03 04:26:24 -0500 | Rating Details | |
2023-09-03 04:17:44 -0500 | Rating Details | |
2023-09-03 03:59:17 -0500 | Rating Details | |
2023-09-03 03:23:11 -0500 | Rating Details | |
2023-09-03 02:43:28 -0500 | Rating Details | |
2023-09-03 02:19:15 -0500 | Rating Details | |
2023-09-03 01:42:09 -0500 | Rating Details | |
2023-09-03 01:41:32 -0500 | Rating Details | |
2023-09-03 01:08:51 -0500 | Rating Details | |
2023-09-03 01:04:05 -0500 | Rating Details | |
2023-09-03 00:27:52 -0500 | Rating Details | |
2023-09-02 23:11:43 -0500 | Rating Details | |
2023-09-02 23:02:02 -0500 | Rating Details | |
2023-09-02 22:57:47 -0500 | Rating Details | |
2023-09-02 22:54:26 -0500 | Rating Details | |
2023-09-02 22:35:11 -0500 | Rating Details | |
2023-09-02 22:31:39 -0500 | Rating Details | |
2023-09-02 22:02:45 -0500 | Rating Details | |
2023-09-02 21:53:44 -0500 | Rating Details | |
2023-09-02 21:33:05 -0500 | Rating Details | |
2023-09-02 21:27:46 -0500 | Rating Details | |
2023-09-02 21:25:22 -0500 | Rating Details | |
2023-09-02 21:19:12 -0500 | Rating Details | |
2023-09-02 21:13:50 -0500 | Rating Details | |
2023-09-02 21:11:49 -0500 | Rating Details | |
2023-09-02 20:58:54 -0500 | Rating Details | |
2023-09-02 20:43:14 -0500 | Rating Details | |
2023-09-02 20:38:44 -0500 | Rating Details | |
2023-09-02 20:35:26 -0500 | Rating Details | |
2023-09-02 20:29:14 -0500 | Rating Details | |
2023-09-02 20:19:29 -0500 | Rating Details | |
2023-09-02 20:14:47 -0500 | Rating Details | |
2023-09-02 20:11:39 -0500 | Rating Details | |
2023-09-02 20:11:18 -0500 | Rating Details | |
2023-09-02 20:06:59 -0500 | Rating Details | |
2023-09-02 19:58:19 -0500 | Rating Details | |
2023-09-02 19:57:37 -0500 | Rating Details | |
2023-09-02 19:53:51 -0500 | Rating Details | |
2023-09-02 19:48:44 -0500 | Rating Details | |
2023-09-02 19:34:31 -0500 | Rating Details | |
2023-09-03 21:22:36 -0500 | Rating Details | |
2023-09-03 19:43:00 -0500 | Rating Details | |
2023-09-06 07:29:38 -0500 | Rating Details | |
2023-09-05 09:18:38 -0500 | Rating Details | |
2023-09-08 23:19:38 -0500 | Rating Details | |
2024-01-15 06:49:47 -0600 | Rating Details | |
2024-01-15 00:50:29 -0600 | Rating Details | |
2024-01-14 20:54:46 -0600 | Rating Details | |
2024-01-14 19:56:24 -0600 | Rating Details | |
2024-01-14 15:33:48 -0600 | Rating Details | |
2024-01-14 15:24:21 -0600 | Rating Details | |
2024-01-14 14:11:24 -0600 | Rating Details | |
2024-01-14 22:12:41 -0600 | Rating Details | |
2024-01-14 21:20:29 -0600 | Rating Details | |
2024-01-14 19:11:42 -0600 | Rating Details | |
2024-01-14 18:36:48 -0600 | Rating Details | |
2024-01-14 15:26:34 -0600 | Rating Details | |
2024-01-14 15:22:54 -0600 | Rating Details | |
2024-01-14 14:56:53 -0600 | Rating Details | |
2024-01-14 14:24:27 -0600 | Rating Details | |
2024-01-14 14:10:08 -0600 | Rating Details | |
2024-01-14 14:05:18 -0600 | Rating Details |